Skip to main content

Mechanisms and Treatment of Chronic Allograft Injury (CAI) Due to Calcineurin Inhibitor (CNI) Toxicity

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Mechanisms and Treatment of Chronic Allograft Injury (CAI) Due to Calcineurin Inhibitor (CNI) Toxicity

Pediatric Chronic Kidney Disease Safety and Efficacy

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Pediatric Chronic Kidney Disease Safety and Efficacy

A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus

Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)

To Assess Safety/Efficacy of ELAD in Subjects w/ Severe Acute Alcoholic Hepatitis (sAAH) and Lille Score Failure

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about To Assess Safety/Efficacy of ELAD in Subjects w/ Severe Acute Alcoholic Hepatitis (sAAH) and Lille Score Failure

Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma

The Optiflow Patency and Maturation Study

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about The Optiflow Patency and Maturation Study

Adjuvant Aflibercept for Metastatic Colorectal Cancer

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Adjuvant Aflibercept for Metastatic Colorectal Cancer

Reversal of Dabigatran Anticoagulant Effect With Idarucizumab

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Reversal of Dabigatran Anticoagulant Effect With Idarucizumab

NGAL As An Aid for the Diagnosis of Acute Kidney Injury in Intensive Care

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about NGAL As An Aid for the Diagnosis of Acute Kidney Injury in Intensive Care

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 50
  • Page 51
  • Page 52
  • Page 53
  • Page 54
  • Page 55
  • Page 56
  • Page 57
  • Page 58
  • …
  • Next page Next
  • Last page Last
Subscribe to